Wang M - Search Results

1

Sputum cell-free DNA: Valued surrogate sample for the detection of EGFR exon 20 p.T790M mutation in patients with advanced lung adenocarcinoma and acquired resistance to EGFR-TKIs.

Wang Z, Li X, Zhang L, Xu Y, Wang M, Liang L, Jiao P, Li Y, He S, Du J, He L, Tang M, Sun M, Yang L, Di J, Zhu G, Li L, Liu D. Wang Z, et al. Among authors: wang m. Cancer Med. 2021 May;10(10):3323-3331. doi: 10.1002/cam4.3817. Epub 2021 May 1. Cancer Med. 2021. PMID: 33932095 Free PMC article.

2

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.

Mu XL, Li LY, Zhang XT, Wang SL, Wang MZ. Mu XL, et al. BMC Cancer. 2004 Aug 19;4:51. doi: 10.1186/1471-2407-4-51. BMC Cancer. 2004. PMID: 15318946 Free PMC article. Clinical Trial.

3

[Treatment of non-small cell lung cancer with gefitinib].

Zhang XT, Li LY, Wang SL, Mu XL, Wang MZ. Zhang XT, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2005 Mar;28(3):180-3. Zhonghua Jie He He Hu Xi Za Zhi. 2005. PMID: 15854414 Chinese.

4

[Gefitinib in the treatment of advanced non-small cell lung cancer with brain metastasis].

Wu C, Li LY, Wang MZ, Zhang L, Zhang XT, Zhong W, Wang SL, Wang HZ. Wu C, et al. Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):943-5. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18478938 Clinical Trial. Chinese.

5

[Efficacy and safety of gefitinib in maintenance therapy for patients with advanced non-small cell lung cancer].

Wang MZ, Zhong W, Zhang L, Li LY, Wang SL, Li JR, Zhang XT. Wang MZ, et al. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):221-4. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756941 Clinical Trial. Chinese.

6

Efficacy and clinical/molecular predictors of erlotinib monotherapy for Chinese advanced non-small cell lung cancer.

Zhu YJ, Xia Y, Ren GJ, Wang MZ, Zeng X, Zhang L. Zhu YJ, et al. Chin Med J (Engl). 2010 Nov;123(22):3200-5. Chin Med J (Engl). 2010. PMID: 21163115

7

[Comparison of EGFR mutation status in paired pre- and post-chemotherapy serum for advanced pulmonary adenocarcinoma].

Han R, Zhong W, Zhao J, Zhang L, Xia Y, Wang H, Li L, Wang M. Han R, et al. Among authors: wang h, wang m. Zhongguo Fei Ai Za Zhi. 2011 Feb;14(2):127-31. doi: 10.3779/j.issn.1009-3419.2011.02.04. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21342642 Free PMC article. Chinese.

8

A novel method for detection of mutation in epidermal growth factor receptor.

Zhao J, Zhao J, Huang J, Chen Y, Jiang J, Wu W, Wang P, Liu L, Li L, Wu L, Wang M, Chen W. Zhao J, et al. Among authors: wang p, wang m. Lung Cancer. 2011 Nov;74(2):226-32. doi: 10.1016/j.lungcan.2011.02.015. Epub 2011 Mar 24. Lung Cancer. 2011. PMID: 21439672

9

Comparison of three methods for detecting epidermal growth factor receptor mutations in plasma DNA samples of Chinese patients with advanced non-small cell lung cancer.

Qin L, Zhong W, Zhang L, Li LY, Wang MZ. Qin L, et al. Chin Med J (Engl). 2011 Mar;124(6):887-91. Chin Med J (Engl). 2011. PMID: 21518597

10

Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer.

Wang HP, Zhang L, Wang YX, Tan FL, Xia Y, Ren GJ, Hu P, Jiang J, Wang MZ, Xiao Y. Wang HP, et al. Chin Med J (Engl). 2011 Jul 5;124(13):1933. Chin Med J (Engl). 2011. PMID: 22088449 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68,524 results

Search Page

Filters